GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Valiant Laboratories Ltd

Valiant Laboratories Reports FY26 Standalone Net Profit of Rs. 554.82 Lakhs

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 14 May 2026, 08:17 PM IST  ·  BSE ID: 473716b5-82de-4f90-9960-229510dffed1
View Original BSE Filing (PDF)
💡
In Simple Terms
The company announced its annual financial results, reporting a standalone net profit of Rs. 554.82 Lakhs for the full year.
🤖 AI Summary
  • Board approved Audited Standalone and Consolidated Financial Results for Q4 and year ended March 31, 2026.
  • Standalone Net Profit for the quarter ended March 31, 2026, was Rs. 353.28 Lakhs.
  • Standalone Net Profit for the year ended March 31, 2026, was Rs. 554.82 Lakhs.
  • Revenue from Operations for FY26 Standalone reached Rs. 21,704.25 Lakhs.
  • Auditors Raman S. Shah & Co. issued their report on the financial results.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Standalone Revenue from Operations (Year Ended March 31, 2026)
21,704.25 Lakhs
62.75%
Standalone Net Profit (Year Ended March 31, 2026)
554.82 Lakhs
Not comparable — limited prior period data.
Standalone Basic EPS (Year Ended March 31, 2026)
1.02 Rs.
Not comparable — limited prior period data.
Standalone Total Income (Year Ended March 31, 2026)
21,993.73 Lakhs
58.48%
Standalone Total Expenses (Year Ended March 31, 2026)
21,238.94 Lakhs
51.44%
🏢 How This Affects the Company
📈
Business Impact
The company's revenue from operations increased to Rs. 21,704.25 Lakhs for FY26, indicating growth in its chemicals business segment.
💰
Financial Impact
Valiant Laboratories reported a standalone net profit of Rs. 554.82 Lakhs for FY26, a turnaround from a net loss of Rs. (215.02) Lakhs in FY25.
⚙️
Operational Impact
The financial results reflect operations as a single segment company, manufacturing chemicals.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, as reported by the Audited Standalone and Consolidated Financial Results for FY26.
🔍
Management Signal
The Board's approval and disclosure of audited financial results signals adherence to regulatory compliance and transparent reporting of company performance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Next quarterly financial results — check for sustained profitability and revenue growth.
Operational updates — monitor any announcements on expansion or new product lines.
Investor calls or presentations — observe management commentary on future outlook.
LOW RISK The filing reports audited financial results with positive turnaround in profitability.
💡 Investor Takeaway
Valiant Laboratories reported a standalone net profit of Rs. 554.82 Lakhs for the year ended March 31, 2026, marking a significant turnaround from a net loss of Rs. (215.02) Lakhs in the prior year. Revenue from operations increased to Rs. 21,704.25 Lakhs.
⚖️ Strengths & Concerns

✅ Positives

  • Standalone net profit for FY26 was Rs. 554.82 Lakhs, a significant improvement from a net loss of Rs. (215.02) Lakhs in FY25.
  • Revenue from Operations for FY26 Standalone increased to Rs. 21,704.25 Lakhs from Rs. 13,336.18 Lakhs in FY25.

⚠️ Concerns

  • Other income for FY26 Standalone decreased to Rs. 289.48 Lakhs from Rs. 542.81 Lakhs in FY25.
  • Total tax expense (Net) for FY26 Standalone increased to Rs. 199.96 Lakhs from Rs. 70.24 Lakhs in FY25.
📅 Company Track Record
Valiant Laboratories Ltd was incorporated in 2021 (CIN L24299MH2021PLC365904). Its IPO was within the last 12 months. Limited public track record is available for comprehensive historical comparisons. Previous filings indicate a standalone net profit of Rs. 554.82 Lakhs for FY26, a turnaround from a loss.

Based on publicly available historical data. For context only.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.